UK-based biotech company FabRx has announced a study exploring how pharmaceutical 3D printing can automate capsule filling in community pharmacies. Published in the International Journal of Pharmaceutics, the research examines the effectiveness of the M3DIMAKER 1 pharmaceutical 3D printer in producing minoxidil capsules, evaluating its cost, time efficiency, and safety compared to traditional manual methods. According to the team, pharmacists often rely on manual compounding, a process that demands time and carries the risk of human error. By using semi-solid extrusion (SSE) technology, the biotech company’s 3D printer simplifies capsule filling, ensuring precise dosing and better consistency. M3DIMAKER 1 pharmaceutical 3D printer with the capsule holder on top of the integrated balance: (A) Full view of the capsule holder- pharmaceutical 3D printer system in a community compounding pharmacy laboratory, (B) Magnified view of the capsule holder within the printer. Image via FabRx. Advanced capsule production with 3D printing One of… read more